A. Rodgers and S. Macmahon, Blood Pressure and the Global Burden of Cardiovascular Disease, Clinical and Experimental Hypertension, vol.4, issue.1, pp.5-6543, 1999.
DOI : 10.1111/j.1467-842X.1997.tb01779.x

S. Yusuf, S. Reddy, S. Ounpuu, S. Anand, N. Ferrara et al., Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization References (1) The biology of vascular endothelial growth factor Multiplexed discovery of sequence polymorphisms using base-specific cleavage and MALDI-TOF MS, Endocr Rev. Nucleic Acids Res, vol.1833, pp.4-25, 1997.

J. Fan, A. Oliphant, R. Shen, B. Kermani, F. Garcia et al., Highly Parallel SNP Genotyping, Cold Spring Harbor Symposia on Quantitative Biology, vol.32, issue.0, pp.69-78, 2003.
DOI : 10.1038/nbt0402-353

M. Chen and Q. Yang, GWAF: an R package for genome-wide association analyses with family data, Bioinformatics, vol.73, issue.Suppl. 1, pp.580-581, 2009.
DOI : 10.1093/biomet/73.1.13

K. Steffensen, M. Waldstrom, I. Brandslund, and A. Jakobsen, The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer, Gynecologic Oncology, vol.117, issue.1, pp.109-116, 2010.
DOI : 10.1016/j.ygyno.2009.11.011

M. Kamoun, M. Houman, A. Hamzaoui, and K. Hamzaoui, Vascular endothelial growth factor gene polymorphisms and serum levels in Beh??et???s disease, Tissue Antigens, vol.30, issue.6, pp.581-587, 2008.
DOI : 10.1042/cs0940395

R. Zhai, M. Gong, W. Zhou, T. Thompson, P. Kraft et al., Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS, Thorax, vol.62, issue.8, pp.718-722, 2007.
DOI : 10.1136/thx.2006.069393

M. Ferrante, M. Pierik, L. Henckaerts, M. Joossens, K. Claes et al., The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease, Inflammatory Bowel Diseases, vol.46, issue.9, pp.870-878, 2006.
DOI : 10.1093/rheumatology/kei013

P. Krippl, U. Langsenlehner, W. Renner, B. Yazdani-biuki, G. Wolf et al., A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk, International Journal of Cancer, vol.22, issue.4, pp.468-471, 2003.
DOI : 10.1161/01.ATV.0000026801.56080.14

T. Awata, K. Inoue, S. Kurihara, T. Ohkubo, M. Watanabe et al., A Common Polymorphism in the 5'-Untranslated Region of the VEGF Gene Is Associated With Diabetic Retinopathy in Type 2 Diabetes, Diabetes, vol.51, issue.5, pp.1635-1639, 2002.
DOI : 10.2337/diabetes.51.5.1635

W. Renner, S. Kotschan, C. Hoffmann, B. Obermayer-pietsch, and E. Pilger, A Common 936 C/T Mutation in the Gene for Vascular Endothelial Growth Factor Is Associated with Vascular Endothelial Growth Factor Plasma Levels, Journal of Vascular Research, vol.37, issue.6
DOI : 10.1159/000054076

M. Petrovic, P. Korosec, M. Kosnik, J. Osredkar, M. Hawlina et al., Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy

T. Cacev, B. Loncar, S. Seiwerth, S. Spaventi, and S. Kapitanovic, mRNA Expression and Susceptibility to Sporadic Colon Cancer, DNA and Cell Biology, vol.27, issue.10, pp.569-574, 2008.
DOI : 10.1089/dna.2008.0756

R. Cosin, J. Gilabert-estelles, L. Ramon, F. Espana, J. Gilabert et al., Vascular endothelial growth factor polymorphisms endometriosis: their influence on vascular endothelial growth factor expression Peripheral blood mononuclear cells (PBMCs): a possible model for studying cardiovascular biology systems, Fertil Steril. Visvikis-Siest S Clin Chem Lab Med, vol.9245, issue.43, pp.1214-12201154, 2007.

B. Keyt, L. Berleau, H. Nguyen, H. Chen, H. Heinsohn et al., The Carboxyl-terminal Domain(111165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency, Journal of Biological Chemistry, vol.11, issue.13, pp.7788-7795, 1996.
DOI : 10.1074/jbc.270.13.7717

S. Tevosian, A. Deconinck, M. Tanaka, M. Schinke, S. Litovsky et al., FOG-2, a Cofactor for GATA Transcription Factors, Is Essential for Heart Morphogenesis and Development of Coronary Vessels from Epicardium, Cell, vol.101, issue.7, pp.729-739, 2000.
DOI : 10.1016/S0092-8674(00)80885-5

H. Song, J. Suehiro, Y. Kanki, Y. Kawai, K. Inoue et al., Critical Role for GATA3 in Mediating Tie2 Expression and Function in Large Vessel Endothelial Cells, Journal of Biological Chemistry, vol.87, issue.42, pp.29109-29124, 2009.
DOI : 10.1161/01.RES.87.1.19

Y. Von-kodolitsch, W. Ito, O. Franzen, G. Lund, D. Koschyk et al., Anomalien der Koronararterien Teil I: Aktuelle Erkenntnisse aus der Embryologie, Zeitschrift f??r Kardiologie, vol.219, issue.12, pp.929-937, 2004.
DOI : 10.1161/01.CIR.75.1.255

N. Loewen, J. Chen, V. Dudley, V. Sarthy, J. Mathura et al., Genomic response of hypoxic M??ller cells involves the very low density lipoprotein receptor as part of an angiogenic network, Experimental Eye Research, vol.88, issue.5, pp.928-937, 2009.
DOI : 10.1016/j.exer.2008.11.037

H. Verheul, K. Hoekman, S. Luykx-de-bakker, C. Eekman, C. Folman et al., Platelet: transporter of vascular endothelial growth factor, Clin Cancer Res, vol.3, pp.2187-2190, 1997.

R. 1. Dawber, T. Kannel, and W. , The Framingham Study An Epidemiological Approach to Coronary Heart Disease, Circulation, vol.34, issue.4, pp.553-555, 1966.
DOI : 10.1161/01.CIR.34.4.553

M. Feinleib, W. Kannel, R. Garrison, P. Mcnamara, and W. Castelli, The framingham offspring study. Design and preliminary data, Preventive Medicine, vol.4, issue.4, pp.518-525, 1975.
DOI : 10.1016/0091-7435(75)90037-7

G. Splansky, D. Corey, Q. Yang, L. Atwood, L. Cupples et al., The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: Design, Recruitment, and Initial Examination, American Journal of Epidemiology, vol.165, issue.11, pp.1328-1335, 2007.
DOI : 10.1093/aje/kwm021

S. Visvikis-siest and G. Siest, The STANISLAS Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseases, Clinical Chemistry and Laboratory Medicine, vol.55, issue.6, pp.733-747, 2008.
DOI : 10.1080/15287390490514895

G. Siest, S. Visvikis, B. Herbeth, R. Gueguen, M. Vincent-viry et al., Objectives, Design and Recruitment of a Familial and Longitudinal Cohort for Studying Gene-Environment Interactions in the Field of Cardiovascular Risk: The Stanislas Cohort, Clinical Chemistry and Laboratory Medicine, vol.35, issue.1, pp.35-42, 1998.
DOI : 10.1016/0009-8981(91)90106-M

L. Lind, N. Fors, J. Hall, K. Marttala, and A. Stenborg, A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly, the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study

S. Fitzgerald, J. Lamont, and R. Mcconnell, Development of a High-Throughput Automated Analyzer Using Biochip Array Technology, Clinical Chemistry, vol.51, issue.7, pp.1165-1176, 2005.
DOI : 10.1373/clinchem.2005.049429

J. Fan, A. Oliphant, R. Shen, B. Kermani, F. Garcia et al., Highly Parallel SNP Genotyping, Cold Spring Harbor Symposia on Quantitative Biology, vol.32, issue.0, pp.69-78, 2003.
DOI : 10.1038/nbt0402-353

A. Price, N. Patterson, R. Plenge, M. Weinblatt, N. Shadick et al., Principal components analysis corrects for stratification in genome-wide association studies, Nature Genetics, vol.15, issue.8, pp.904-909, 2006.
DOI : 10.1111/j.1469-1809.1949.tb02451.x

N. Patterson, A. Price, and D. Reich, Population Structure and Eigenanalysis, PLoS Genetics, vol.15, issue.12, p.190, 2006.
DOI : 1088-9051(2005)015[1576:CACSOH]2.0.CO;2

S. Grundy, J. Cleeman, S. Daniels, K. Donato, R. Eckel et al., Diagnosis and management of the metabolic syndrome, Current Opinion in Cardiology, vol.21, issue.1, pp.2735-2752, 2005.
DOI : 10.1097/01.hco.0000200416.65370.a0

M. Chen and Q. Yang, GWAF: an R package for genome-wide association analyses with family data, Bioinformatics, vol.73, issue.Suppl. 1, pp.580-581
DOI : 10.1093/biomet/73.1.13

H. Ma, X. Zhao, Y. Yuan, and A. Zeng, Decomposition of metabolic network into functional modules based on the global connectivity structure of reaction graph, Bioinformatics, vol.20, issue.12, pp.1870-1876, 2004.
DOI : 10.1093/bioinformatics/bth167

J. Marteau, S. Mohr, M. Pfister, and S. Visvikis-siest, Collection and Storage of Human Blood Cells for mRNA Expression Profiling: A 15-Month Stability Study, Clinical Chemistry, vol.51, issue.7, pp.1250-1252, 2005.
DOI : 10.1373/clinchem.2005.048546

S. Mourah, R. Porcher, G. Lescaille, P. Rousselot, M. Podgorniak et al., Quantification of VEGF Isoforms and VEGFR Transcripts by qRT-PCR and Their Significance in Acute Myeloid Leukemia, The International Journal of Biological Markers, vol.102, issue.1, pp.22-31, 2009.
DOI : 10.1182/blood-2002-10-2998

N. Costa, S. Paramanathan, M. Donald, D. Wierzbicki, A. Hampson et al., Factors regulating circulating vascular endothelial growth factor (VEGF): Association with bone mineral density (BMD) in post-menopausal osteoporosis, Cytokine, vol.46, issue.3, pp.376-381, 2009.
DOI : 10.1016/j.cyto.2009.03.012

A. Medford, S. Godinho, L. Keen, J. Bidwell, and A. Millar, Relationship Between Vascular Endothelial Growth Factor + 936 Genotype and Plasma/Epithelial Lining Fluid Vascular Endothelial Growth Factor Protein Levels in Patients With and at Risk for ARDS, Chest, vol.136, issue.2, pp.457-464, 2009.
DOI : 10.1378/chest.09-0383

U. Langsenlehner, G. Wolf, T. Langsenlehner, A. Gerger, G. Hofmann et al., Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian ???tumor of breast tissue: incidence, genetics, and environmental risk factors??? study, Breast Cancer Research and Treatment, vol.103, issue.2, pp.297-304, 2008.
DOI : 10.1007/s10549-007-9655-z

I. Mateo, J. Llorca, J. Infante, E. Rodriguez-rodriguez, C. Fernandez-viadero et al., Low serum VEGF levels are associated with Alzheimer's disease, Acta Neurologica Scandinavica, vol.31, issue.1, pp.56-58, 2007.
DOI : 10.1016/S0197-4580(03)00111-8

H. Berrahmoune, B. Herbeth, J. Lamont, C. Masson, and P. Fitzgerald, Heritability for Plasma VEGF Concentration in the Stanislas Family Study, Annals of Human Genetics, vol.266, issue.1, pp.54-63, 2007.
DOI : 10.1161/hc0902.104718

K. Steffensen, M. Waldstrom, I. Brandslund, and A. Jakobsen, The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer, Gynecologic Oncology, vol.117, issue.1, pp.109-116
DOI : 10.1016/j.ygyno.2009.11.011

M. Kamoun, M. Houman, A. Hamzaoui, and K. Hamzaoui, Vascular endothelial growth factor gene polymorphisms and serum levels in Beh??et???s disease, Tissue Antigens, vol.30, issue.6, pp.581-587, 2008.
DOI : 10.1042/cs0940395

R. Zhai, M. Gong, W. Zhou, T. Thompson, P. Kraft et al., Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS, Thorax, vol.62, issue.8, pp.718-722, 2007.
DOI : 10.1136/thx.2006.069393

M. Ferrante, M. Pierik, L. Henckaerts, M. Joossens, K. Claes et al., The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease, Inflammatory Bowel Diseases, vol.46, issue.9, pp.870-878, 2006.
DOI : 10.1093/rheumatology/kei013

P. Krippl, U. Langsenlehner, W. Renner, B. Yazdani-biuki, G. Wolf et al., A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk, International Journal of Cancer, vol.22, issue.4
DOI : 10.1161/01.ATV.0000026801.56080.14

T. Awata, K. Inoue, S. Kurihara, T. Ohkubo, M. Watanabe et al., A Common Polymorphism in the 5'-Untranslated Region of the VEGF Gene Is Associated With Diabetic Retinopathy in Type 2 Diabetes, Diabetes, vol.51, issue.5, pp.1635-1639, 2002.
DOI : 10.2337/diabetes.51.5.1635

W. Renner, S. Kotschan, C. Hoffmann, B. Obermayer-pietsch, and E. Pilger, A Common 936 C/T Mutation in the Gene for Vascular Endothelial Growth Factor Is Associated with Vascular Endothelial Growth Factor Plasma Levels, Journal of Vascular Research, vol.37, issue.6, pp.443-448, 2000.
DOI : 10.1159/000054076

C. Krieglstein and D. Granger, Adhesion molecules and their role in vascular disease, American Journal of Hypertension, vol.14, issue.11, 2001.
DOI : 10.1016/S0895-7061(01)02069-6

E. Galkina and K. Ley, Vascular Adhesion Molecules in Atherosclerosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.27, issue.11, pp.2292-301, 2007.
DOI : 10.1161/ATVBAHA.107.149179

C. Weber and H. Noels, Atherosclerosis: current pathogenesis and therapeutic options, Nature Medicine, vol.147, issue.11, pp.1410-1432, 2011.
DOI : 10.1161/ATVBAHA.109.202671

H. Dvorak, Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy, Journal of Clinical Oncology, vol.20, issue.21, pp.4368-80, 2002.
DOI : 10.1200/JCO.2002.10.088

N. Ferrara, H. Gerber, and J. Lecouter, The biology of VEGF and its receptors, Nature Medicine, vol.99, issue.21, pp.669-76, 2003.
DOI : 10.1073/pnas.152324099

S. Kiriakidis, E. Andreakos, C. Monaco, B. Foxwell, M. Feldmann et al., VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2, Journal of Cell Science, vol.116, issue.4, pp.665-74, 2003.
DOI : 10.1242/jcs.00286

S. Debette, S. Visvikis-siest, M. Chen, N. Ndiaye, C. Song et al., Identification of cis- and trans-Acting Genetic Variants Explaining Up to Half the Variation in Circulating Vascular Endothelial Growth Factor Levels, Circulation Research, vol.109, issue.5, pp.554-63, 2011.
DOI : 10.1161/CIRCRESAHA.111.243790

S. Visvikis-siest and G. Siest, The STANISLAS Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseases, Clinical Chemistry and Laboratory Medicine, vol.55, issue.6, pp.733-780, 2008.
DOI : 10.1080/15287390490514895

S. Fitzgerald, J. Lamont, R. Mcconnell, and B. Eo, Development of a High-Throughput Automated Analyzer Using Biochip Array Technology, Clinical Chemistry, vol.51, issue.7, pp.1165-76, 2005.
DOI : 10.1373/clinchem.2005.049429

J. Marteau, S. Mohr, M. Pfister, and S. Visvikis-siest, Collection and Storage of Human Blood Cells for mRNA Expression Profiling: A 15-Month Stability Study, Clinical Chemistry, vol.51, issue.7, pp.1250-1252, 2005.
DOI : 10.1373/clinchem.2005.048546

M. Ehrich, S. Bocker, and D. Van-den-boom, Multiplexed discovery of sequence polymorphisms using base-specific cleavage and MALDI-TOF MS, Nucleic Acids Research, vol.33, issue.4, p.38, 2005.
DOI : 10.1093/nar/gni038

S. Purcell, N. B. Todd-brown, K. Thomas, L. Ferreira, M. Bender et al., PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses, The American Journal of Human Genetics, vol.81, issue.3, pp.559-75, 2007.
DOI : 10.1086/519795

I. Kim, S. Moon, S. Kim, H. Kim, Y. Koh et al., Vascular Endothelial Growth Factor Expression of Intercellular Adhesion Molecule 1 (ICAM-1), Vascular Cell Adhesion Molecule 1 (VCAM-1), and E-selectin through Nuclear Factor-??B Activation in Endothelial Cells, Journal of Biological Chemistry, vol.9, issue.10, pp.2767614-2767634, 2001.
DOI : 10.1038/sj.mn.7300155

B. Rabquer, M. Amin, N. Teegala, M. Shaheen, P. Tsou et al., Junctional Adhesion Molecule-C Is a Soluble Mediator of Angiogenesis, The Journal of Immunology, vol.185, issue.3, pp.1777-85, 2010.
DOI : 10.4049/jimmunol.1000556

A. Koch, M. Halloran, C. Haskell, M. Shah, and P. Polverini, Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1, Nature, vol.376, issue.6540, pp.517-526, 1995.
DOI : 10.1038/376517a0

W. Somers, J. Tang, G. Shaw, and R. Camphausen, Insights into the Molecular Basis of Leukocyte Tethering and Rolling Revealed by Structures of P- and E-Selectin Bound to SLeX and PSGL-1, Cell, vol.103, issue.3, pp.467-79, 2000.
DOI : 10.1016/S0092-8674(00)00138-0

L. Zhao, M. Shey, M. Farnsworth, and M. Dailey, Regulation of Membrane Metalloproteolytic Cleavage of L-selectin (CD62L) by the Epidermal Growth Factor Domain, Journal of Biological Chemistry, vol.267, issue.33, 2001.
DOI : 10.1073/pnas.96.7.3922

H. Berrahmoune, B. Herbeth, J. Lamont, C. Masson, P. Fitzgerald et al., Heritability for Plasma VEGF Concentration in the Stanislas Family Study, Annals of Human Genetics, vol.266, issue.1, pp.54-63, 2007.
DOI : 10.1161/hc0902.104718

J. Xu and M. Zou, Molecular Insights and Therapeutic Targets for Diabetic Endothelial Dysfunction, Circulation, vol.120, issue.13, pp.1266-86, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.835223

URL : http://circ.ahajournals.org/content/circulationaha/120/13/1266.full.pdf

H. Aziz, A. Zaas, and G. Ginsburg, Peripheral blood gene expression profiling for cardiovascular disease assessment, Genomic Medicine, vol.39, issue.3-4, pp.3-4105, 2007.
DOI : 10.1161/hy0302.104670

S. Visvikis-siest, J. Marteau, A. Samara, H. Berrahmoune, M. B. Pfister et al., Peripheral blood mononuclear cells (PBMCs): a possible model for studying cardiovascular biology systems, Clinical Chemical Laboratory Medicine, vol.32, issue.9, pp.1154-68, 2007.
DOI : 10.2337/diabetes.53.7.1857

S. Ghosh and D. Baltimore, Activation in vitro of NF-??B" by phosphorylation of its inhibitor I??B", Nature, vol.344, issue.6267, pp.678-82, 1990.
DOI : 10.1038/344678a0

E. Boyle, J. Kovacich, J. Canty, T. , J. Morgan et al., Inhibition of nuclear factor-kappa B nuclear localization reduces human E-selectin expression and the systemic inflammatory response, Circulation, pp.98-282, 1998.

H. Ledebur and T. Parks, Transcriptional Regulation of the Intercellular Adhesion Molecule-1 Gene by Inflammatory Cytokines in Human Endothelial Cells, Journal of Biological Chemistry, vol.13, issue.2, pp.933-976, 1995.
DOI : 10.1128/MCB.13.11.7180

C. Wrighton, R. Hofer-warbinek, T. Moll, R. Eytner, F. Bach et al., Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B, Journal of Experimental Medicine, vol.183, issue.3, pp.1013-1035, 1996.
DOI : 10.1084/jem.183.3.1013

J. Suh and A. Rabson, NF-?B activation in human prostate cancer: Important mediator or epiphenomenon?, Journal of Cellular Biochemistry, vol.1, issue.1, pp.100-117, 2004.
DOI : 10.1016/S1097-2765(00)80066-0

M. Mohammadi, M. Bazrafshani, P. Day, and W. Ollier, Vascular endothelial growth factor production is regulated by gene polymorphisms, Iran J Immunol, vol.6, issue.3, pp.119-148, 2009.

J. Westra, G. Molema, and C. Kallenberg, Hypoxia-Inducible Factor-1 as Regulator of Angiogenesis in Rheumatoid Arthritis - Therapeutic Implications, Current Medicinal Chemistry, vol.17, issue.3, pp.254-63, 2010.
DOI : 10.2174/092986710790149783

M. Bottomley, N. Webb, C. Watson, L. Holt, M. Bukhari et al., Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid, Clinical and Experimental Immunology, vol.8, issue.1, pp.182-190, 2000.
DOI : 10.1006/cimm.1995.9978

E. Paleolog, S. Young, A. Stark, R. Mccloskey, M. Feldmann et al., Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis, Arthritis Rheum, issue.467, pp.411258-65, 1998.

S. Yoshida, M. Ono, T. Shono, H. Izumi, T. Ishibashi et al., Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis., Molecular and Cellular Biology, vol.17, issue.7, pp.4015-4038, 1997.
DOI : 10.1128/MCB.17.7.4015

Y. Zhou, O. Genbacev, and S. Fisher, The Human Placenta Remodels the Uterus by Using a Combination of Molecules That Govern Vasculogenesis or Leukocyte Extravasation, Annals of the New York Academy of Sciences, vol.40, issue.1, 2003.
DOI : 10.1016/S0002-9440(10)62567-9

T. Waddell, L. Fialkow, C. Chan, T. Kishimoto, and G. Downey, Signaling Functions of L-selectin, Journal of Biological Chemistry, vol.269, issue.25, pp.15403-15414, 1995.
DOI : 10.1006/bbrc.1994.1819

M. Ancelin, S. Chollet-martin, M. Herve, C. Legrand, B. El et al., Vascular endothelial growth factor VEGF189 induces human neutrophil chemotaxis in extravascular tissue via an autocrine amplification mechanism, Laboratory Investigation, vol.101, issue.4, pp.502-514, 2004.
DOI : 10.1111/j.1471-0528.1994.tb13690.x

Q. Hao, L. Wang, and H. Tang, Vascular endothelial growth factor induces protein kinase D-dependent production of proinflammatory cytokines in endothelial cells, American Journal of Physiology-Cell Physiology, vol.296, issue.4, pp.821-827, 2009.
DOI : 10.1161/01.HYP.0000138688.78906.6b

Z. Poltorak, T. Cohen, R. Sivan, Y. Kandelis, G. Spira et al., , a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular Matrix, Journal of Biological Chemistry, vol.302, issue.11, pp.2727151-2727159, 1997.
DOI : 10.3109/08977199509003209

S. Mourah, R. Porcher, G. Lescaille, P. Rousselot, M. Podgorniak et al., Quantification of VEGF Isoforms and VEGFR Transcripts by qRT-PCR and Their Significance in Acute Myeloid Leukemia, The International Journal of Biological Markers, vol.102, issue.1, pp.22-31, 2009.
DOI : 10.1182/blood-2002-10-2998

H. Wada, N. Satoh, S. Kitaoka, K. Ono, T. Morimoto et al., Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance, Atherosclerosis, vol.208, issue.2, pp.512-519, 2010.
DOI : 10.1016/j.atherosclerosis.2009.07.045

S. Grundy, Metabolic Syndrome: A Multiplex Cardiovascular Risk Factor, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.2, pp.399-404, 2007.
DOI : 10.1210/jc.2006-0513

R. Eckel, S. Grundy, and P. Zimmet, The metabolic syndrome, The Lancet, vol.365, issue.9468, pp.1415-1443, 2005.
DOI : 10.1016/S0140-6736(05)66378-7

P. Miranda, R. Defronzo, R. Califf, and J. Guyton, Metabolic syndrome: Definition, pathophysiology, and mechanisms, American Heart Journal, vol.149, issue.1, pp.33-45, 2005.
DOI : 10.1016/j.ahj.2004.07.013

O. Osborn and J. Olefsky, The cellular and signaling networks linking the immune system and metabolism in disease, Nature Medicine, vol.152, issue.3, pp.363-74, 2012.
DOI : 10.2337/db10-1278

D. Ochiai, N. Goda, T. Hishiki, M. Kanai, N. Senoo-matsuda et al., Disruption of HIF-1alpha in hepatocytes impairs glucose metabolism in diet-induced obesity mice

M. Cornier, D. Dabelea, T. Hernandez, R. Lindstrom, A. Steig et al., The Metabolic Syndrome, Endocrine Reviews, vol.29, issue.7, pp.777-822, 2008.
DOI : 10.1210/er.2008-0024

W. Van, V. De, V. Voshol, P. Verloop, R. Eilers et al., Hypercholesterolemia reduces collateral artery growth more dominantly than 261

N. Ferrara, Vascular Endothelial Growth Factor: Basic Science and Clinical Progress, Endocrine Reviews, vol.25, issue.4
DOI : 10.1210/er.2003-0027

Y. Cao, Angiogenesis modulates adipogenesis and obesity, Journal of Clinical Investigation, vol.117, issue.9, pp.2362-2370, 2007.
DOI : 10.1172/JCI32239

S. Debette, S. Visvikis-siest, M. Chen, N. Ndiaye, C. Song et al., Identification of cis- and trans-Acting Genetic Variants Explaining Up to Half the Variation in Circulating Vascular Endothelial Growth Factor Levels, Circulation Research, vol.109, issue.5, pp.554-63, 2011.
DOI : 10.1161/CIRCRESAHA.111.243790

I. Elias, S. Franckhauser, T. Ferre, L. Vila, S. Tafuro et al., Adipose Tissue Overexpression of Vascular Endothelial Growth Factor Protects Against Diet-Induced Obesity and Insulin Resistance, Diabetes, vol.61, issue.7, 2012.
DOI : 10.2337/db11-0832

I. Jialal, G. Fadini, K. Pollock, and S. Devaraj, Circulating Levels of Endothelial Progenitor Cell Mobilizing Factors in the Metabolic Syndrome, The American Journal of Cardiology, vol.106, issue.11, pp.1606-1614, 2010.
DOI : 10.1016/j.amjcard.2010.07.039

G. Tarantino, R. Lobello, F. Scopacasa, F. Contaldo, F. Pasanisi et al., The contribution of omental adipose tissue to adipokine concentrations in patients with the metabolic syndrome, Clinical & Investigative Medicine, vol.30, issue.5, pp.192-199, 2007.
DOI : 10.25011/cim.v30i5.2895

W. Lieb, R. Safa, E. Benjamin, V. Xanthakis, X. Yin et al., Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor, p.262

A. Kraja, D. Vaidya, J. Pankow, M. Goodarzi, T. Assimes et al., A Bivariate Genome-Wide Approach to Metabolic Syndrome: STAMPEED Consortium, Diabetes, vol.60, issue.4, pp.1329-1368, 2011.
DOI : 10.2337/db10-1011

D. Zabaneh and D. Balding, A Genome-Wide Association Study of the Metabolic Syndrome in Indian Asian Men, PLoS ONE, vol.41, issue.1, p.11961, 2010.
DOI : 10.1371/journal.pone.0011961.s010

B. Herbeth, A. Samara, C. Ndiaye, J. Marteau, H. Berrahmoune et al., Metabolic syndrome-related composite factors over 5 years in the STANISLAS family study: genetic heritability and common environmental influences, Clin Chim Acta, vol.411, pp.11-12833, 2010.

M. Azimi-nezhad, B. Herbeth, G. Siest, S. Dade, N. Ndiaye et al., High Prevalence of Metabolic Syndrome in Iran in Comparison with France: What Are the Components That Explain This?, Metabolic Syndrome and Related Disorders, vol.10, issue.3, pp.181-189, 2012.
DOI : 10.1089/met.2011.0097

M. Nezhad, M. Ghayour-mobarhan, S. Parizadeh, M. Safarian, H. Esmaeili et al., Metabolic syndrome: Its prevalence and relationship to socio-economic parameters in an Iranian population, Nutrition, Metabolism and Cardiovascular Diseases, vol.18, issue.3, pp.11-12, 2008.
DOI : 10.1016/j.numecd.2007.07.005

M. Ehrich, S. Bocker, and D. Van-den-boom, Multiplexed discovery of sequence polymorphisms using base-specific cleavage and MALDI-TOF MS, Nucleic Acids Research, vol.33, issue.4, p.38, 2005.
DOI : 10.1093/nar/gni038

S. Purcell, N. B. Todd-brown, K. Thomas, L. Ferreira, M. Bender et al., PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses, The American Journal of Human Genetics, vol.81, issue.3, pp.559-75, 2007.
DOI : 10.1086/519795

W. Yu, M. Gwinn, M. Clyne, A. Yesupriya, and M. Khoury, A navigator for human genome epidemiology, Nature Genetics, vol.38, issue.2, pp.124-129, 2008.
DOI : 10.1038/ng0208-124

L. Hindorff, P. Sethupathy, H. Junkins, E. Ramos, J. Mehta et al., Potential etiologic and functional implications of genome-wide association loci for human diseases and traits, Proceedings of the National Academy of Sciences, vol.40, issue.3, pp.9362-9369, 2009.
DOI : 10.1038/ng.91

C. Lorenzo, K. Williams, K. Hunt, and S. Haffner, The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes, Diabetes Care, vol.30, issue.1, pp.8-13, 2007.
DOI : 10.2337/dc06-1414

S. Schiekofer, G. Galasso, K. Sato, B. Kraus, and K. Walsh, Impaired Revascularization in a Mouse Model of Type 2 Diabetes Is Associated With Dysregulation of a Complex Angiogenic-Regulatory Network, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, issue.8, pp.1603-1612, 2005.
DOI : 10.1161/01.ATV.0000171994.89106.ca

J. Despres, I. Lemieux, J. Bergeron, P. Pibarot, P. Mathieu et al., Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.28, issue.6
DOI : 10.1161/ATVBAHA.107.159228

URL : http://atvb.ahajournals.org/content/atvbaha/28/6/1039.full.pdf

A. Blann, F. Belgore, J. Constans, C. Conri, and G. Lip, Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate, The American Journal of Cardiology, vol.87, issue.10, pp.1160-1163, 2001.
DOI : 10.1016/S0002-9149(01)01486-2

C. Ersoy, S. Kiyici, F. Budak, B. Oral, M. Guclu et al., The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients, Diabetes Research and Clinical Practice, vol.81, issue.1, pp.56-60, 2008.
DOI : 10.1016/j.diabres.2008.02.006

S. Mcilroy, M. Vahidassr, D. Savage, C. Patterson, J. Lawson et al., Risk of Alzheimer's disease is associated with a very low-density lipoprotein receptor genotype in northern Ireland, American Journal of Medical Genetics, vol.100, issue.2, pp.140-144, 1999.
DOI : 10.1007/s004390050488

K. Argraves, K. Kozarsky, J. Fallon, P. Harpel, and D. Strickland, The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor., Journal of Clinical Investigation, vol.100, issue.9, pp.2170-81, 1997.
DOI : 10.1172/JCI119753

S. Takahashi, J. Sakai, T. Fujino, H. Hattori, Y. Zenimaru et al., The Very Low-density Lipoprotein (VLDL) Receptor: Characterization and Functions as a Peripheral Lipoprotein Receptor, Journal of Atherosclerosis and Thrombosis, vol.11, issue.4, pp.200-208, 2004.
DOI : 10.5551/jat.11.200

J. Goudriaan, P. Tacken, V. Dahlmans, M. Gijbels, K. Van-dijk et al., Protection From Obesity in Mice Lacking the VLDL Receptor, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.21, issue.9, pp.1488-93, 2001.
DOI : 10.1161/hq0901.095147

J. Perman, P. Bostrom, M. Lindbom, U. Lidberg, M. Stahlman et al., The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction, Journal of Clinical Investigation, vol.121, issue.7, pp.2625-2665, 2011.
DOI : 10.1172/JCI43068DS1

Y. Zenimaru, S. Takahashi, M. Takahashi, K. Yamada, T. Iwasaki et al., Glucose deprivation accelerates VLDL receptor-mediated TG-rich lipoprotein uptake by AMPK activation in skeletal muscle cells, Biochemical and Biophysical Research Communications, vol.368, issue.3, pp.716-738, 2008.
DOI : 10.1016/j.bbrc.2008.01.154

M. Pedrini, M. Kranebitter, A. Niederwanger, S. Kaser, J. Engl et al., Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels, Diabetologia, vol.5, issue.Suppl 1, pp.756-66, 2005.
DOI : 10.1007/s00125-005-1684-8

D. Coletta and L. Mandarino, Mitochondrial dysfunction and insulin resistance from the outside in: extracellular matrix, the cytoskeleton, and mitochondria, American Journal of Physiology-Endocrinology and Metabolism, vol.2, issue.5, pp.749-755, 2011.
DOI : 10.1039/b701483j

I. Zachary and G. Gliki, Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family, Cardiovascular Research, vol.49, issue.3, pp.568-81, 2001.
DOI : 10.1016/S0008-6363(00)00268-6

K. Miyokawa-gorin, K. Takahashi, K. Handa, A. Kitahara, Y. Sumitani et al., Induction of mitochondrial uncoupling enhances VEGF(120) but reduces MCP-1

H. Karakelides, Y. Asmann, M. Bigelow, K. Short, K. Dhatariya et al., Effect of Insulin Deprivation on Muscle Mitochondrial ATP Production and Gene Transcript Levels in Type 1 Diabetic Subjects, Diabetes, vol.56, issue.11, pp.2683-2692, 2007.
DOI : 10.2337/db07-0378

N. Ottschytsch, A. Raes, H. Van, and D. Snyders, Obligatory heterotetramerization of three previously uncharacterized Kv channel alpha-subunits identified in the human genome

Z. Berwick, G. Dick, and J. Tune, Heart of the matter: Coronary dysfunction in metabolic syndrome, Journal of Molecular and Cellular Cardiology, vol.52, issue.4, pp.848-56, 2012.
DOI : 10.1016/j.yjmcc.2011.06.025

Z. Berwick, G. Dick, S. Moberly, M. Kohr, M. Sturek et al., Contribution of voltage-dependent K+ channels to metabolic control of coronary blood flow, Journal of Molecular and Cellular Cardiology, vol.52, issue.4, pp.912-921, 2012.
DOI : 10.1016/j.yjmcc.2011.07.004

P. Macdonald, S. Sewing, J. Wang, J. Joseph, S. Smukler et al., Channels in Pancreatic ??-Cells Enhances Glucose-dependent Insulin Secretion, Journal of Biological Chemistry, vol.1283, issue.47, pp.44938-44983, 2002.
DOI : 10.1016/0079-6107(89)90013-8

H. Watada, Role of VEGF-A in Pancreatic Beta Cells, Endocrine Journal, vol.57, issue.3, pp.185-91, 2010.
DOI : 10.1507/endocrj.K09E-035

R. Foster, R. Hole, K. Anderson, S. Satchell, R. Coward et al., Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes, American Journal of Physiology-Renal Physiology, vol.60, issue.6, pp.1263-1273, 2003.
DOI : 10.1042/cs0970303

URL : http://ajprenal.physiology.org/content/ajprenal/284/6/F1263.full.pdf

J. Deeney, K. Tornheim, H. Korchak, M. Prentki, and B. Corkey, Acyl-CoA esters modulate intracellular Ca2+ handling by permeabilized clonal pancreatic beta-cells, J Biol Chem, vol.267, issue.28, pp.19840-19845, 1992.

D. Muoio and C. Newgard, Molecular and metabolic mechanisms of insulin resistance and ??-cell failure in type 2 diabetes, Nature Reviews Molecular Cell Biology, vol.132, issue.3, pp.193-205, 2008.
DOI : 10.1172/JCI200422230

G. Dick, I. Bratz, L. Borbouse, G. Payne, U. Dincer et al., channels regulate the duration of reactive hyperemia in the canine coronary circulation, American Journal of Physiology-Heart and Circulatory Physiology, vol.294, issue.5, pp.2371-2381, 2008.
DOI : 10.1073/pnas.93.19.10489

R. 1. Carmeliet, P. , and R. K. Jain, Molecular mechanisms and clinical applications of angiogenesis, Nature, vol.464, issue.7347, pp.298-307, 2011.
DOI : 10.1038/nature08889

S. Yla-herttuala, T. T. Rissanen, I. Vajanto, and J. Hartikainen, Vascular Endothelial Growth Factors, Journal of the American College of Cardiology, vol.49, issue.10, pp.1015-1026, 2007.
DOI : 10.1016/j.jacc.2006.09.053

C. Vaklavas, D. Lenihan, R. Kurzrock, and A. M. Tsimberidou, Anti-Vascular Endothelial Growth Factor Therapies and Cardiovascular Toxicity: What Are the Important Clinical Markers to Target?, The Oncologist, vol.15, issue.2, pp.130-141, 2010.
DOI : 10.1634/theoncologist.2009-0252

B. S. Chin, N. A. Chung, C. R. Gibbs, A. D. Blann, and G. Y. Lip, Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure, The American Journal of Cardiology, vol.90, issue.11, pp.1258-1260, 2002.
DOI : 10.1016/S0002-9149(02)02848-5

. Shimada, Expression of vascular endothelial growth factor in patients with acute myocardial infarction, J Am Coll Cardiol, vol.35, pp.968-973, 2000.

M. Slevin, J. Krupinski, A. Slowik, P. Kumar, A. Szczudlik et al., Serial Measurement of Vascular Endothelial Growth Factor and Transforming Growth Factor-??1 in Serum of Patients With Acute Ischemic Stroke, Stroke, vol.31, issue.8, pp.1863-1870, 2000.
DOI : 10.1161/01.STR.31.8.1863

F. M. Belgore, A. D. Blann, F. L. Li-saw-hee, D. G. Beevers, and G. Y. Lip, Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension, The American Journal of Cardiology, vol.87, issue.6, pp.805-807, 2001.
DOI : 10.1016/S0002-9149(00)01512-5

K. Yonemura, M. Higashi, H. Ayaori, F. Nakamura, and . Ohsuzu, Plasma vascular endothelial growth factor level is elevated in patients with multivessel coronary artery disease, 2004.

J. F. Ferrara, I. Martin, M. Zachary, and . Simons, Angiogenesis-dependent and independent phases of intimal hyperplasia, Circulation, vol.110, pp.2436-2443, 2004.

J. Hayry, K. Wood, S. Alitalo, P. K. Yla-herttuala, and . Koskinen, Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis, Circulation, vol.105, pp.2524-2530, 2002.

K. Gillies, J. Javaherian, and . Folkman, Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis, Proc Natl Acad Sci, vol.100, pp.4736-4741, 2003.

M. Risau, M. Soma, J. F. Laakso, S. Martin, and . Yla-herttuala, VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries, Hum Gene Ther, vol.8, pp.1737-1744, 1997.

. Yla-herttuala, Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipoproteinreceptor/apolipoprotein B48-deficient mice, Circulation, vol.112, pp.1347-1352, 2005.

B. J. Arsenault, S. M. Boekholdt, and J. J. Kastelein, Lipid parameters for measuring risk of cardiovascular disease, Nature Reviews Cardiology, vol.25, issue.4, pp.197-206, 2011.
DOI : 10.1016/S0828-282X(09)70715-9

A. D. Blann, F. M. Belgore, J. Constans, C. Conri, and G. Y. Lip, Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate, The American Journal of Cardiology, vol.87, issue.10, pp.1160-1163, 2001.
DOI : 10.1016/S0002-9149(01)01486-2

F. M. Belgore, G. Y. Lip, A. D. Blann, T. Hashiguchi, T. Deguchi et al., Successful therapy reduces levels of vascular endothelial growth factor (VEGF) in patients with hypertension and patients with hypercholesterolemia, Atherosclerosis, vol.151, issue.2, 2000.
DOI : 10.1016/S0021-9150(00)00477-9

M. Maruyama, K. Osame, and . Arimura, Serum VEGF--as a prognostic factor of atherosclerosis, Atherosclerosis, vol.194, pp.182-188, 2007.

. Schratzberger, Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study, Atherosclerosis, vol.206, pp.265-269, 2009.

J. Choi, L. Lamont, Q. Lind, P. Yang, E. Fitzgerald et al., Identification of cis-and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels, Circ Res, vol.109, pp.554-563, 2011.

J. Lecomte, J. Steinmetz, P. Locuty, S. Chevrier, and G. Siest, Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: the Stanislas cohort The STANISLAS Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseases, Clin Chem Lab Med Clin Chem Lab Med, vol.36, issue.46, pp.35-42, 1998.

W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, 1972.

M. , S. Bocker, D. Van-den, and . Boom, Multiplexed discovery of sequence polymorphisms using base-specific cleavage and MALDI-TOF MS, Clin Chem Nucleic Acids Res, vol.18, issue.33, pp.499-502, 2005.

P. I. Sklar, M. J. De-bakker, P. C. Daly, and . Sham, PLINK: a tool set for whole-genome association and population-based linkage analyses, Am J Hum Genet, vol.81, pp.559-575, 2007.

W. Yu, M. Gwinn, M. Clyne, A. Yesupriya, and M. J. Khoury, A navigator for human genome epidemiology, Nature Genetics, vol.38, issue.2, pp.124-125, 2008.
DOI : 10.1038/ng0208-124

A. Manolio, Potential etiologic and functional implications of genome-wide association loci for human diseases and traits, Proc Natl Acad Sci, vol.106, pp.9362-9367, 2009.

F. Wichmann and . Kronenberg, Genome-wide association analysis of high-density lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions, Circ Cardiovasc Genet, vol.1, pp.10-20, 2008.

G. Ordovas, E. Berglund, P. Vartiainen, B. Jousilahti, M. R. Hedblad et al., Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans, Nat Genet, vol.40, pp.189-197, 2008.

K. L. Abecasis, L. A. Mohlke, and . Cupples, Common variants at 30 loci contribute to polygenic dyslipidemia, Nat Genet, vol.41, pp.56-65, 2009.

Y. D. Rotter, I. B. Chen, and . Borecki, A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium, Diabetes, vol.60, pp.1329-1339, 2011.

L. Freimer, D. Peltonen, and J. Hadley, Genome-wide association analysis of metabolic traits in a birth cohort from a founder population, Nat Genet, vol.41, pp.35-46, 2009.

C. M. Barter, J. S. Van-duijn, L. Kooner, N. J. Peltonen, R. Wareham et al., Genetic variants influencing circulating lipid levels and risk of coronary artery disease, Arterioscler Thromb Vasc Biol, vol.30, pp.2264-2276, 2010.

R. Watanabe, S. Nagaraja, D. A. Ebrahim, Y. Lawlor, G. Ben-shlomo et al., Newly identified loci that influence lipid concentrations and risk of coronary artery disease, Nat Genet, vol.40, pp.161-169, 2008.

H. Berrahmoune, J. V. Lamont, B. Herbeth, P. S. Fitzgerald, and S. Visvikis-siest, Biological Determinants of and Reference Values for Plasma Interleukin-8, Monocyte Chemoattractant Protein-1, Epidermal Growth Factor, and Vascular Endothelial Growth Factor: Results from the STANISLAS Cohort, 43. Hunter, D. J. 2005. Gene-environment interactions in human diseases, pp.504-510, 2006.
DOI : 10.1373/clinchem.2005.055798

T. A. Manolio, Genomewide Association Studies and Assessment of the Risk of Disease, New England Journal of Medicine, vol.363, issue.2, pp.166-176, 2010.
DOI : 10.1056/NEJMra0905980

P. Miranda, R. Defronzo, and R. Califf, Metabolic syndrome: Definition, pathophysiology, and mechanisms, American Heart Journal, vol.149, issue.1, pp.33-45, 2005.
DOI : 10.1016/j.ahj.2004.07.013

S. Grundy, J. Cleeman, and S. Daniels, Diagnosis and management of the metabolic syndrome, Current Opinion in Cardiology, vol.21, issue.1, pp.2735-2752, 2005.
DOI : 10.1097/01.hco.0000200416.65370.a0

K. Alberti, P. Zimmet, and J. Shaw, Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation, Diabetic Medicine, vol.46, issue.5, pp.469-480, 2006.
DOI : 10.1001/jama.290.4.486

F. Azizi, F. Hadaegh, and D. Khalili, Appropriate definition of metabolic syndrome among Iranian adults

R. Mabry, M. Reeves, and E. Eakin, Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review, Diabetic Medicine, vol.13, issue.5, pp.593-597, 2010.
DOI : 10.1111/j.1467-789X.2009.00655.x

B. Herbeth, A. Samara, and C. Ndiaye, Metabolic syndrome-related composite factors over 5 years in the STANISLAS family study: Genetic heritability and common environ-mental influences, Clin Chim Acta, vol.3411, pp.833-839, 2010.

M. Azimi-nezhad, M. Ghayour-mobarhan, and M. Parizadeh, Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation, Singapore Med J, vol.49, pp.571-576, 2008.

M. Nezhad, M. Ghayour-mobarhan, and S. Parizadeh, Metabolic syndrome: Its prevalence and relationship to socio-economic parameters in an Iranian population, Nutrition, Metabolism and Cardiovascular Diseases, vol.18, issue.3, pp.11-12, 2008.
DOI : 10.1016/j.numecd.2007.07.005

F. Azizi, P. Salehi, and A. Etemadi, Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study, Diabetes Research and Clinical Practice, vol.61, issue.1, pp.29-37, 2003.
DOI : 10.1016/S0168-8227(03)00066-4

Z. Heidari, F. Hosseinpanah, and Y. Mehrabi, Predictive power of the components of metabolic syndrome in its development: a 6.5-year follow-up in the Tehran Lipid and Glucose Study (TLGS), European Journal of Clinical Nutrition, vol.77, issue.10, pp.1207-1214, 2010.
DOI : 10.2337/dc07-0959

M. Anvari, M. Boroumand, and L. Pourgholi, Potential Link of Microalbuminuria with Metabolic Syndrome in Patients Undergoing Coronary Angiography, Archives of Medical Research, vol.40, issue.5, pp.399-405, 2009.
DOI : 10.1016/j.arcmed.2009.06.011

M. Delavar, M. Lye, and G. Khor, Prevalence of meta-bolic syndrome among middle aged women in Babol, Iran. Southeast Asian J Trop Med Public Health, vol.40, pp.612-628, 2009.

A. Delavari, M. Forouzanfar, and S. Alikhani, First Nationwide Study of the Prevalence of the Metabolic Syndrome and Optimal Cutoff Points of Waist Circumference in the Middle East: The National Survey of Risk Factors for Noncommunicable Diseases of Iran, Diabetes Care, vol.32, issue.6, pp.1092-1097, 2009.
DOI : 10.2337/dc08-1800

P. Ebrahimpour, H. Fakhrzadeh, and R. Pourebrahim, Metabolic Syndrome and Related Insulin Levels in Obese Children, Metabolic Syndrome and Related Disorders, vol.4, issue.3, pp.172-178, 2006.
DOI : 10.1089/met.2006.4.172

A. Esmaillzadeh, P. Mirmiran, and L. Azadbakht, High Prevalence of the Metabolic Syndrome in Iranian Adolescents*, Obesity, vol.6, issue.3, pp.377-382, 2006.
DOI : 10.1038/oby.2006.50

S. Lejeune and J. Mourad, [Metabolic syndrome: Epidemiology and its risks], Ann Dermatol Venereol, vol.135, pp.249-253, 2008.

J. Dallongeville, D. Cottel, and J. Ferrieres, Household Income Is Associated With the Risk of Metabolic Syndrome in a Sex-Specific Manner, Diabetes Care, vol.28, issue.2, pp.409-415, 2005.
DOI : 10.2337/diacare.28.2.409

L. Guize, F. Thomas, and B. Pannier, Metabolic syndrome: Prevalence, risk factors and mortality in a French population of 62 000 subjects], Bull Acad Natl Med, vol.190, pp.685-697, 2006.

N. Ahluwalia, L. Drouet, and J. Ruidavets, Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample, Atherosclerosis, vol.186, issue.2, pp.345-353, 2006.
DOI : 10.1016/j.atherosclerosis.2005.07.021

B. Balkau, M. Vernay, and L. Mhamdi, The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study, Diabetes & Metabolism, vol.29, issue.5, pp.526-532, 2003.
DOI : 10.1016/S1262-3636(07)70067-8

B. Bauduceau, F. Baigts, and L. Bordier, Epidemiology of the metabolic syndrome in 2045 French military personnel (EPIMIL study), Diabetes & Metabolism, vol.31, issue.4, pp.353-359, 2005.
DOI : 10.1016/S1262-3636(07)70204-5

V. Bataille, B. Perret, and J. Dallongeville, Metabolic syn-drome and coronary heart disease risk in a population-based study of middle-aged men from France and Northern Ire-land. A nested case-control study from the PRIME cohort, Diabetes Metab, vol.32, issue.5, 2006.

B. Maisonneuve, C. Auclair, and M. Ali, Pr??valence des anomalies m??taboliques chez l???enfant ob??se, Archives de P??diatrie, vol.16, issue.7, pp.991-998, 2009.
DOI : 10.1016/j.arcped.2009.03.022

S. Maumus, M. B. Siest, and G. , A Prospective Study on the Prevalence of Metabolic Syndrome Among Healthy French Families: Two cardiovascular risk factors (HDL cholesterol and tumor necrosis factor-??) are revealed in the offspring of parents with metabolic syndrome, Diabetes Care, vol.28, issue.3, pp.675-682, 2005.
DOI : 10.2337/diacare.28.3.675

B. Pannier, F. Thomas, and E. Eschwege, Cardiovascular risk markers associated with the metabolic syndrome in a large French population: the SYMFONIE study, Diabetes & Metabolism, vol.32, issue.5, pp.467-474, 2006.
DOI : 10.1016/S1262-3636(07)70305-1